General Information of the Compound
Compound ID |
CP0014050
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
MLS000110334
Show/Hide
|
||||||||||||||||||
Synonyms |
(3-carbazol-9-yl-2-hydroxypropyl)(2-furylmethyl)(methylsulfonyl)amine
10.14272/OQAFDLPAPSSOHY-UHFFFAOYSA-N
309928-48-1
AKOS000581142
AKOS016386481
BDBM56256
BIM-0006034.P001
BRD-A94580299-001-08-8
CB08282
CBMicro_005790
CHEMBL1498001
ChemDiv2_003790
EU-0005302
F1345-0456
HMS1379M06
HMS2371E17
IDI1_002505
KL-001
KL001
KL001(KL-001;KL 001)
MCULE-8116422943
MLS000110334
MLS002540427
MLS006011739
N-(3-(9H-carbazol-9-yl)-2-hydroxypropyl)-N-(furan-2-ylmethyl)methanesulfonamide
N-(3-carbazol-9-yl-2-hydroxy-propyl)-N-(2-furfuryl)methanesulfonamide
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(furan-2-ylmethyl)methanesulfonamide
N-(3-carbazol-9-yl-2-oxidanyl-propyl)-N-(furan-2-ylmethyl)methanesulfonamide
N-[3-(9-carbazolyl)-2-hydroxypropyl]-N-(2-furanylmethyl)methanesulfonamide
N-[3-(9H-Carbazol-9-yl)-2-hydroxypropyl]-N-(2-furanylmethyl)methanesulfonamide
N-[3-(9H-Carbazol-9-yl)-2-hydroxypropyl]-N-[(furan-2-yl)methyl]methanesulfonamide
N-[3-(9H-carbazol-9-yl)-2-hydroxypropyl]-N-(furan-2-ylmethyl)methanesulfonamide
NCGC00079434-02
NCGC00079434-03
NCGC00079434-06
Oprea1_152161
Oprea1_419357
SCHEMBL15380452
SMR000106264
SMSF0015860
SR-01000436091
SR-01000436091-1
ST50257205
STK839587
cid_2888648
doi:10.14272/OQAFDLPAPSSOHY-UHFFFAOYSA-N
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C21H22N2O4S
|
||||||||||||||||||
Molecular Weight |
398.484
|
||||||||||||||||||
Canonical SMILES |
CS(=O)(=O)N(CC(O)Cn1c2ccccc2c2ccccc12)Cc1ccco1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C21H22N2O4S/c1-28(25,26)22(15-17-7-6-12-27-17)13-16(24)14-23-20-10-4-2-8-18(20)19-9-3-5-11-21(19)23/h2-12,16,24H,13-15H2,1H3
Show/Hide
|
||||||||||||||||||
InChIKey |
OQAFDLPAPSSOHY-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06500, Cryptochrome-1
Protein ID: PT06468, Period circadian protein homolog 2
Clinical Information about the Compound